Dublin, Jan. 21, 2025 (GLOBE NEWSWIRE) — The “Pharmaceutical Manufacturing Software Market Report 2024” has been added to ResearchAndMarkets.com’s offering.
The pharmaceutical manufacturing software market size is expected to see rapid growth in the next few years. It will grow to $5.91 billion in 2028 at a compound annual growth rate (CAGR) of 15.7%. The anticipated growth during the forecast period can be attributed to advancements in personalized medicine, increased investment in R&D, a heightened focus on supply chain optimization, expansion in the biopharmaceutical sector, and escalating global health challenges.
Key trends expected include the adoption of AI, cloud-based solutions, real-time monitoring, integration of IoT technologies, and advancements in quality management.
The growth of the pharmaceutical manufacturing software market is expected to rise with the increase in drug production. Drug production involves the systematic creation of pharmaceutical products, including their formulation, testing, and packaging, to ensure their quality, safety, and efficacy.
As global demand for medications grows, increasing drug production is essential to address public health needs and provide timely treatments for various medical conditions. Pharmaceutical manufacturing software aids this process by streamlining operations, improving data accuracy, optimizing resource use, and ensuring compliance with regulations, which enhances overall efficiency and scalability. For example, the European Federation of Pharmaceutical Industries and Associations (EFPIA) reported in June 2023 that the European pharmaceutical industry’s production increased from $352.48 billion in 2021 to $369.95 billion in 2022. This expansion in drug production is expected to drive the growth of the pharmaceutical manufacturing software market.
Key players in the pharmaceutical manufacturing software market are focusing on process optimization through the integration of advanced manufacturing technologies, including AI-powered tools. These tools leverage artificial intelligence to improve predictive analytics, streamline manufacturing processes, and boost operational efficiency. For instance, in February 2024, Mareana, a US-based provider of AI-driven analytics and supply chain solutions for the pharmaceutical and life sciences sectors, introduced Connect CMC, an AI-powered tool aimed at transforming data management for smaller pharmaceutical and biotech firms. This tool enhances efficiency, accuracy, and cost-effectiveness by automating data extraction from paper batch records and ensuring GxP compliance, driving digital innovation in drug development.
In May 2023, Antares Vision Group, an Italy-based provider of industrial solutions, acquired Smart Point Technologies. This acquisition is intended to enhance Antares Vision Group’s range of solutions by incorporating Smart Point Technologies’ specialized software expertise. The deal aims to improve operational efficiencies, meet strict regulatory and compliance standards, and expand market presence. Smart Point Technologies, based in India, offers pharmaceutical manufacturing software solutions.
Major companies operating in the pharmaceutical manufacturing software market are McKesson, Oracle, SAP, ABB, Rockwell Automation, Dassault Systemes, NetSuite, The Sage Group, Epicor Software, QAD, Intellect Design Arena, Columbus Manufacturing, MasterControl, Sapphire Systems, Deskera, Vormittag Associates, Logic ERP Solutions, SYSPRO, Datacor, BatchMaster Software, Fishbowl, Aquilon Software, CompuTec, ERPAG and MRPeasy.
This report focuses on pharmaceutical manufacturing software market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
Markets Covered:
- By Software Type: Manufacturing Execution Systems (MES); Enterprise Resource Planning (ERP) Systems; Laboratory Information Management Systems (LIMS); Quality Management Systems (QMS); Process Analytical Technology (PAT) Systems; Regulatory Compliance Software
- By Deployment Mode: On-Premises; Cloud-Based
- By Application: Large Enterprise; Small And Midsize Enterprise
- By End-User: Biopharmaceutical Companies; Medical Device Companies; Contract Research Organizations; Academic Research Institutions; Other End Users
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 175 |
| Forecast Period | 2024 – 2028 |
| Estimated Market Value (USD) in 2024 | $3.3 Billion |
| Forecasted Market Value (USD) by 2028 | $5.91 Billion |
| Compound Annual Growth Rate | 15.7% |
| Regions Covered | Global |
Key Topics Covered:
1. Executive Summary
2. Pharmaceutical Manufacturing Software Market Characteristics
3. Pharmaceutical Manufacturing Software Market Trends and Strategies
4. Pharmaceutical Manufacturing Software Market – Macro Economic Scenario
5. Global Pharmaceutical Manufacturing Software Market Size and Growth
5.1. Global Pharmaceutical Manufacturing Software Market Drivers and Restraints
5.2. Global Pharmaceutical Manufacturing Software Historic Market Size and Growth, 2018-2023, Value ($ Billion)
5.3. Global Pharmaceutical Manufacturing Software Forecast Market Size and Growth, 2023-2028, 2033F, Value ($ Billion)
6. Pharmaceutical Manufacturing Software Market Segmentation
6.1. Global Pharmaceutical Manufacturing Software Market, Segmentation by Software Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- Manufacturing Execution Systems (MES)
- Enterprise Resource Planning (ERP) Systems
- Laboratory Information Management Systems (LIMS)
- Quality Management Systems (QMS)
- Process Analytical Technology (PAT) Systems
- Regulatory Compliance Software
6.2. Global Pharmaceutical Manufacturing Software Market, Segmentation by Deployment Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
6.3. Global Pharmaceutical Manufacturing Software Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- Large Enterprise
- Small and Midsize Enterprise
6.4. Global Pharmaceutical Manufacturing Software Market, Segmentation by End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- Biopharmaceutical Companies
- Medical Device Companies
- Contract Research Organizations
- Academic Research Institutions
- Other End Users
7. Pharmaceutical Manufacturing Software Market Regional and Country Analysis
7.1. Global Pharmaceutical Manufacturing Software Market, Split by Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Pharmaceutical Manufacturing Software Market, Split by Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8-29. Country Specific Pharmaceutical Manufacturing Software Market Analysis
30. Pharmaceutical Manufacturing Software Market Competitive Landscape and Company Profiles
30.1. Pharmaceutical Manufacturing Software Market Competitive Landscape
30.2. Pharmaceutical Manufacturing Software Market Company Profiles
30.2.1. McKesson
30.2.2. Oracle
30.2.3. SAP
30.2.4. ABB
30.2.5. Rockwell Automation
31. Pharmaceutical Manufacturing Software Market Other Major and Innovative Companies
31.1. Dassault Systemes
31.2. NetSuite
31.3. The Sage Group
31.4. Epicor Software Corporation
31.5. QAD Inc.
31.6. Intellect Design Arena Ltd.
31.7. Columbus Manufacturing Inc.
31.8. MasterControl Inc.
31.9. Sapphire Systems Ltd.
31.10. DESKERA
31.11. Vormittag Associates Inc.
31.12. Logic ERP Solutions
31.13. SYSPRO
31.14. Datacor Inc.
31.15. BatchMaster Software Inc.
32. Global Pharmaceutical Manufacturing Software Market Competitive Benchmarking
33. Global Pharmaceutical Manufacturing Software Market Competitive Dashboard
34. Key Mergers and Acquisitions in the Pharmaceutical Manufacturing Software Market
35. Pharmaceutical Manufacturing Software Market Future Outlook and Potential Analysis
35.1 Countries Offering Most New Opportunities
35.2 Segments Offering Most New Opportunities
35.3 Growth Strategies
For more information about this report visit https://www.researchandmarkets.com/r/8g2utv
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
- Pharmaceutical Manufacturing Software Market
